Fig. 13From: The past, present and future of anti-malarial medicinesKey stages in the hit to lead pathway of AN13762. Initial replacement of the carboxylic acid chain with a pyrazine, and subsequent switch of the ester to a substituted amide helped to improve in vivo stability and bioavailability leading to the optimized compoundBack to article page